Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Viruses with deletions in antiapoptotic genes as potential oncolytic agents

Oncogene volume 24, pages 6069–6079 (2005)Cite this article

Abstract

Replication-selective oncolytic viruses have emerged as a new treatment platform for cancers. However, selectivity and potency need to be improved before virotherapy can become a standard treatment modality. In addition, mechanisms that can be incorporated to enable targeting a broad range of cancer types are highly desirable. Cancer cells are well known to have multiple blocks in apoptosis pathways. On the other hand, viruses have evolved to express numerous antiapoptotic genes to antagonize apoptosis induced upon infection. Viruses with deletions in antiapoptotic genes can therefore be complemented by antiapoptotic genetic changes in cancer cells for efficient replication and oncolysis. In this review, we summarize the recent development of this concept, the potential obstacles, and future directions for optimization.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Alcami A, Khanna A, Paul NL and Smith GL . (1999). J. Gen. Virol., 80, 949–959.

  • Alcami A and Smith GL . (1995). J. Virol., 69, 4633–4639.

  • Alcami A, Symons JA and Smith GL . (2000). J. Virol., 74, 11230–11239.

  • Barker DD and Berk AJ . (1987). Virology, 156, 107–121.

  • Beattie E, Kauffman EB, Martinez H, Perkus ME, Jacobs BL, Paoletti E and Tartaglia J . (1996). Virus Genes, 12, 89–94.

  • Bennett JJ, Delman KA, Burt BM, Mariotti A, Malhotra S, Zager J, Petrowsky H, Mastorides S, Federoff H and Fong Y . (2002). Cancer Gene Ther., 9, 935–945.

  • Bergmann M, Romirer I, Sachet M, Fleischhacker R, Garcia-Sastre A, Palese P, Wolff K, Pehamberger H, Jakesz R and Muster T . (2001). Cancer Res., 61, 8188–8193.

  • Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A and McCormick F . (1996). Science, 274, 373–376.

  • Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D'Sa-Eipper C and Chinnadurai G . (1994). Cell, 79, 341–351.

  • Burgert HG, Ruzsics Z, Obermeier S, Hilgendorf A, Windheim M and Elsing A . (2002). Curr. Top. Microbiol. Immunol., 269, 273–318.

  • Canale VC and Smith CH . (1967). J. Pediatr., 70, 891–899.

  • Carroll K, Elroy-Stein O, Moss B and Jagus R . (1993). J. Biol. Chem., 268, 12837–12842.

  • Cascallo M, Capella G, Mazo A and Alemany R . (2003). Cancer Res., 63, 5544–5550.

  • Cassady KA and Gross M . (2002). J. Virol., 76, 2029–2035.

  • Chen P, Tian J, Kovesdi I and Bruder JT . (1998). J. Biol. Chem., 273, 5815–5820.

  • Cheng EH, Nicholas J, Bellows DS, Hayward GS, Guo HG, Reitz MS and Hardwick JM . (1997). Proc. Natl. Acad. Sci. USA, 94, 690–694.

  • Chinnadurai G . (1998). Semin. Virol., 8, 399–408.

  • Chinnadurai G, Chinnadurai S and Brusca J . (1979). J. Virol., 32, 623–628.

  • Chiou SK, Tseng CC, Rao L and White E . (1994). J. Virol., 68, 6553–6566.

  • Coffey MC, Strong JE, Forsyth PA and Lee PW . (1998). Science, 282, 1332–1334.

  • Colamonici OR, Domanski P, Sweitzer SM, Larner A and Buller RM . (1995). J. Biol. Chem., 270, 15974–15978.

  • Coultas L and Strasser A . (2003). Semin. Cancer Biol., 13, 115–123.

  • Davies MV, Chang HW, Jacobs BL and Kaufman RJ . (1993). J. Virol., 67, 1688–1692.

  • Deveraux QL and Reed JC . (1999). Genes Dev., 13, 239–252.

  • Di Cristofano A and Pandolfi PP . (2000). Cell, 100,387–390.

  • Dobner T, Horikoshi N, Rubenwolf S and Shenk T . (1996). Science, 272, 1470–1473.

  • Gomez-Manzano C, Balague C, Alemany R, Lemoine MG, Mitlianga P, Jiang H, Khan A, Alonso M, Lang FF, Conrad CA, Liu TJ, Bekele BN, Yung WK and Fueyo J . (2004). Oncogene, 23, 1821–1828.

  • Green DR and Reed JC . (1998). Science, 281, 1309–1312.

  • Hagglund R and Roizman B . (2004). J. Virol., 78, 2169–2178.

  • Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini J and Tschopp J . (1996). Science, 274, 1363–1366.

  • Hallden G, Hill R, Wang Y, Anand A, Liu T, Lemoine NR, Francis J, Hawkins L and Kirn D . (2003). Mol. Ther., 8, 412–424.

  • Heise C, Hermiston T, Johnson L, Brooks G, Sampson-Johannes A, Williams A, Hawkins L and Kirn D . (2000). Nat. Med., 6, 1134–1139.

  • Hengartner MO . (2000). Nature, 407, 770–776.

  • Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, Okazaki T, Yamamoto K and Sasada M . (1998). J. Exp. Med., 187, 587–600.

  • Hofmann K, Bucher P and Tschopp J . (1997). Trends. Biochem. Sci., 22, 155–156.

  • Huang DC and Strasser A . (2000). Cell, 103, 839–842.

  • Johnstone RW, Ruefli AA and Lowe SW . (2002). Cell, 108, 153–164.

  • Jones N and Shenk T . (1979). Cell, 17, 683–689.

  • Katze MG, DeCorato D and Safer B . (1987). EMBO J., 6, 689–697.

  • Katze MG, He Y and Gale Jr M . (2002). Nat. Rev. Immunol., 2, 675–687.

  • Kettle S, Alcami A, Khanna A, Ehret R, Jassoy C and Smith GL . (1997). J. Gen. Virol., 78, 677–685.

  • Kettle S, Blake NW, Law KM and Smith GL . (1995). Virology, 206, 136–147.

  • Kim J, Cho JY, Kim JH, Jung KC and Yun CO . (2002). Cancer Gene Ther., 9, 725–736.

  • Kirn D . (2000). Oncogene, 6660–6668.

  • Kirn D . (2001a). Gene Therapy, 8, 89–98.

  • Kirn D . (2001b). Expert Opin. Biol. Ther., 1, 525–538.

  • Kirn D, Martuza RL and Zwiebel J . (2001). Nat. Med., 7, 781–787.

  • Krajcsi P, Dimitrov T, Hermiston TW, Tollefson AE, Ranheim TS, Vande Pol SB, Stephenson AH and Wold WS . (1996). J. Virol., 70, 4904–4913.

  • Langland JO and Jacobs BL . (2002). Virology, 299, 133–141.

  • Legrand FA, Verardi PH, Jones LA, Chan KS, Peng Y and Yilma TD . (2004). J. Virol., 78, 2770–2779.

  • Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ and Virgin HW . (1999). J. Exp. Med., 189, 663–672.

  • Leppard KN and Everett RD . (1999). J. Gen. Virol., 80, 997–1008.

  • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X . (1997). Cell, 91, 479–489.

  • Liu TC, Hallden G, Wang Y, Brooks G, Francis J, Lemoine N and Kirn D . (2004). Mol. Ther., 9, 786–803.

  • Liu ZG, Hsu H, Goeddel DV and Karin M . (1996). Cell, 87, 565–576.

  • Lorence RM, Rood PA and Kelley KW . (1988). J. Natl. Cancer Inst., 80, 1305–1312.

  • Martuza RL, Malick A, Markert JM, Ruffner KL and Coen DM . (1991). Science, 252, 854–856.

  • McNees AL and Gooding LR . (2002). Virus. Res., 88, 87–101.

  • Mineta T, Rabkin SD, Yazaki T, Hunter WD and Martuza RL . (1995). Nat. Med., 1, 938–943.

  • Moise AR, Grant JR, Vitalis TZ and Jefferies WA . (2002). J. Virol., 76, 1578–1587.

  • Moss B, Gershowitz A, Stringer JR, Holland LE and Wagner EK . (1977). J. Virol., 23, 234–239.

  • Mossman KL and Smiley JR . (2002). J. Virol., 76, 1995–1998.

  • Muster T, Rajtarova J, Sachet M, Unger H, Fleischhacker R, Romirer I, Grassauer A, Url A, Garcia-Sastre A, Wolff K, Pehamberger H and Bergmann M . (2004). Int. J. Cancer., 110, 15–21.

  • Najarro P, Traktman P and Lewis JA . (2001). J. Virol., 75, 3185–3196.

  • Nava VE, Cheng EH, Veliuona M, Zou S, Clem RJ, Mayer ML and Hardwick JM . (1997). J. Virol., 71, 4118–4122.

  • Ozoren N and El-Deiry WS . (2003). Semin. Cancer Biol., 13, 135–147.

  • Peters GA, Khoo D, Mohr I and Sen GC . (2002). J. Virol., 76, 11054–11064.

  • Poppers J, Mulvey M, Khoo D and Mohr I . (2000). J. Virol., 74, 11215–11221.

  • Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC and Perucho M . (1997). Science, 275, 967–969.

  • Ries SJ, Brandts CH, Chung AS, Biederer CH, Hann BC, Lipner EM, McCormick F and Korn WM . (2000). Nat. Med., 6, 1128–1133.

  • Roth W and Reed JC . (2002). Nat. Med., 8, 216–218.

  • Russell SJ . (2002). Cancer Gene Ther., 9, 961–966.

  • Sauthoff H, Heitner S, Rom WN and Hay JG . (2000). Hum. Gene Ther., 11, 379–388.

  • Shen Y, Kitzes G, Nye JA, Fattaey A and Hermiston T . (2001). J. Virol., 75, 4297–4307.

  • Smith GL, Howard ST and Chan YS . (1989). J. Gen. Virol., 70, 2333–2343.

  • Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C and Lowe SW . (2001). Nature, 409, 207–211.

  • Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N and Bell JC . (2000). Nat. Med., 6, 821–825.

  • Tarodi B, Subramanian T and Chinnadurai G . (1994). Virology, 201, 404–407.

  • Telling G, Perera S and Williams J . (1994). J. Virol., 68, 541–547.

  • Todo T, Feigenbaum F, Rabkin SD, Lakeman F, Newsome JT, Johnson PA, Mitchell E, Belliveau D, Ostrove JM and Martuza RL . (2000). Mol. Ther., 2, 588–595.

  • Tollefson AE, Toth K, Doronin K, Kuppuswamy M, Doronina OA, Lichtenstein DL, Hermiston TW, Smith CA and Wold WS . (2001). J. Virol., 75, 8875–8887.

  • Verardi PH, Jones LA, Aziz FH, Ahmad S and Yilma TD . (2001). J. Virol., 75, 11–18.

  • Vogelstein B, Lane D and Levine AJ . (2000). Nature, 408, 307–310.

  • Wang Y, Hallden G, Hill R, Anand A, Liu TC, Francis J, Brooks G, Lemoine N and Kirn D . (2003). Nat. Biotechnol., 21, 1328–1335.

  • White E and Cipriani R . (1990). Mol. Cell Biol., 10, 120–130.

  • White E, Grodzicker T and Stillman BW . (1984). J. Virol., 52, 410–419.

  • White E, Sabbatini P, Debbas M, Wold WS, Kusher DI and Gooding LR . (1992). Mol. Cell Biol., 12, 2570–2580.

  • Wickham TJ . (2003). Nat. Med., 9, 135–139.

  • Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X . (1997). Science, 275, 1129–1132.

  • Zhirnov OP, Konakova TE, Wolff T and Klenk HD . (2002). J. Virol., 76, 1617–1625.

Download references

Author information

Authors and Affiliations

  1. Molecular Neurosurgery Laboratory, Massachusetts General Hospital and Harvard Medical School, MA, USA

    Ta-Chiang Liu

  2. Department of Clinical Pharmacology, University of Oxford, UK

    David Kirn

  3. Jennerex Biotherapeutics, Inc., Mountain View, CA, USA

    David Kirn

Authors
  1. Ta-Chiang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Kirn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Ta-Chiang Liu or David Kirn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, TC., Kirn, D. Viruses with deletions in antiapoptotic genes as potential oncolytic agents. Oncogene 24, 6069–6079 (2005). https://doi.org/10.1038/sj.onc.1208734

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208734

Keywords

This article is cited by

Search

Advanced search

Quick links